Tags

Type your tag names separated by a space and hit enter

Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report.
Diabetes Technol Ther. 2010 Apr; 12(4):287-90.DT

Abstract

BACKGROUND

Many Moslem patients do observe the fast during Ramadan. There are limited data on insulin pump therapy during Ramadan. We report our experience with type 1 diabetes patients on insulin pumps during Ramadan 2008 (29 days).

PATIENTS AND METHODS

A total of 63 patients were evaluated. Forty-nine patients fasted, and 14 elected not to fast. Those who fasted (24 males, 25 females) were 22 +/- 7 years of age (mean +/- SD) and had had diabetes for 9.6 +/- 5.6 years. Patients used the Medtronic (Northridge, CA) MiniMed 722 model and had been using pump therapy for 20 +/- 10 months. Outcome measures included number of days fasted, hypoglycemia, unusual hyperglycemia, and number of emergency hospital visits.

RESULTS

Thirty patients (61.2%) fasted the whole month with no problems, nine (18.4%) fasted 27-28 days, eight (16.3%) fasted 24-25 days, and two (4.1%) fasted 23 days. Nearly half of the patients decreased their basal insulin by 5-50% of their prefasting doses. Seventeen patients had hypoglycemia requiring breaking the fast. Fasting was broken on 55 out of 1,450 potential fasting days (3.8%). No severe hypoglycemia was reported by any patient. Unusual hyperglycemia was reported in nine patients (18.4%). Hospital visits were reported for one patient for hyperglycemia (a 16-year-old girl who disconnected her pump). Twelve patients had fructosamine levels measured both before and immediately after Ramadan; pre-Ramadan fructosamine level was 4.0 +/- 0.6 mmol/L, and the post-Ramadan value was 3.6 +/- 0.6 mmol/L (P = 0.007).

CONCLUSIONS

Fasting during Ramadan is feasible in patients with type 1 diabetes using an insulin pump, with adequate counseling and support.

Authors+Show Affiliations

Center for Diabetes and Endocrinology , Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. mbenbarka@skmc.gov.aeNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20210567

Citation

Benbarka, Mahmoud M., et al. "Insulin Pump Therapy in Moslem Patients With Type 1 Diabetes During Ramadan Fasting: an Observational Report." Diabetes Technology & Therapeutics, vol. 12, no. 4, 2010, pp. 287-90.
Benbarka MM, Khalil AB, Beshyah SA, et al. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report. Diabetes Technol Ther. 2010;12(4):287-90.
Benbarka, M. M., Khalil, A. B., Beshyah, S. A., Marjei, S., & Awad, S. A. (2010). Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report. Diabetes Technology & Therapeutics, 12(4), 287-90. https://doi.org/10.1089/dia.2009.0130
Benbarka MM, et al. Insulin Pump Therapy in Moslem Patients With Type 1 Diabetes During Ramadan Fasting: an Observational Report. Diabetes Technol Ther. 2010;12(4):287-90. PubMed PMID: 20210567.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report. AU - Benbarka,Mahmoud M, AU - Khalil,Ali B, AU - Beshyah,Salem A, AU - Marjei,Suhad, AU - Awad,Samar Abu, PY - 2010/3/10/entrez PY - 2010/3/10/pubmed PY - 2010/6/9/medline SP - 287 EP - 90 JF - Diabetes technology & therapeutics JO - Diabetes Technol Ther VL - 12 IS - 4 N2 - BACKGROUND: Many Moslem patients do observe the fast during Ramadan. There are limited data on insulin pump therapy during Ramadan. We report our experience with type 1 diabetes patients on insulin pumps during Ramadan 2008 (29 days). PATIENTS AND METHODS: A total of 63 patients were evaluated. Forty-nine patients fasted, and 14 elected not to fast. Those who fasted (24 males, 25 females) were 22 +/- 7 years of age (mean +/- SD) and had had diabetes for 9.6 +/- 5.6 years. Patients used the Medtronic (Northridge, CA) MiniMed 722 model and had been using pump therapy for 20 +/- 10 months. Outcome measures included number of days fasted, hypoglycemia, unusual hyperglycemia, and number of emergency hospital visits. RESULTS: Thirty patients (61.2%) fasted the whole month with no problems, nine (18.4%) fasted 27-28 days, eight (16.3%) fasted 24-25 days, and two (4.1%) fasted 23 days. Nearly half of the patients decreased their basal insulin by 5-50% of their prefasting doses. Seventeen patients had hypoglycemia requiring breaking the fast. Fasting was broken on 55 out of 1,450 potential fasting days (3.8%). No severe hypoglycemia was reported by any patient. Unusual hyperglycemia was reported in nine patients (18.4%). Hospital visits were reported for one patient for hyperglycemia (a 16-year-old girl who disconnected her pump). Twelve patients had fructosamine levels measured both before and immediately after Ramadan; pre-Ramadan fructosamine level was 4.0 +/- 0.6 mmol/L, and the post-Ramadan value was 3.6 +/- 0.6 mmol/L (P = 0.007). CONCLUSIONS: Fasting during Ramadan is feasible in patients with type 1 diabetes using an insulin pump, with adequate counseling and support. SN - 1557-8593 UR - https://www.unboundmedicine.com/medline/citation/20210567/Insulin_pump_therapy_in_Moslem_patients_with_type_1_diabetes_during_Ramadan_fasting:_an_observational_report_ L2 - https://www.liebertpub.com/doi/10.1089/dia.2009.0130?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -